Antipas, Leonardo A.
HRN: 21-53-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/14/2022
07/21/2022
IV
1.5g
Q6
Cellulitis, Right Leg
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes